why choose us

First received: November 23, 2022

Clinical Trial: Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Transthyretin Amyloidosis

Study Type: INTERVENTIONAL


Official Title: A Follow-Up Study to Monitor Therapeutic Response in Transthyretin Cardiac Amyloidosis Using Amyloid Reactive Peptide 124I-evuzamitide (AT01) PET/CT

Brief Summary: This is a single center, prospective cohort study that is evaluating the ability of 124I-evuzamitide PET scanning to detect potential therapeutic changes in subjects under treatment for ATTR after one year has elapsed since their original 124I-evuzamitide PET scan.Ten previously scanned subjects will re-consent to undergo another 124I-evuzamitide PET scan.Demographic, clinical and phenotypic data will be collected to characterize potential changes since their previous scans.

Read more